Axcan Pharma acquired; stock ceases trading

By Lisa Kerner

Charlotte, N.C., Feb. 25 - All of the common shares of Axcan Pharma Inc. have been acquired by an affiliate of TPG Capital, Axcan announced on Monday.

As a result, Axcan shares will cease trading on the Nasdaq Global Market and on the Toronto Stock Exchange.

Axcan, a Mont-Saint-Hilaire, Quebec-based specialty pharmaceutical company, agreed to be acquired by TPG and its affiliates in an all-cash transaction valued at some $1.3 billion, or $23.35 per common share.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.